Blog, News and Press Releases

We are revolutionizing the translational potential of animal models in preclinical research. Discover the latest articles and news about our recent activities.

Attending the International HBV Meeting 2022

PhoenixBio is thrilled to be attending the International HBV Meeting in person at the Novotel Paris Centre Tour Eiffel in Paris, France on September 18th - 22nd, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance future therapies for viral hepatitis (HBV, HDV/HBV, HCV), Gene Editing, Gene Therapy, Drug Metabolism, Pharmacokinetics, and Toxicology.

Topics icon Exhibition, Events

HBV Meeting

Attending EASL's International Liver Congress

PhoenixBio is thrilled to be attending EASL's International Liver Congress in person at the ExCeL in London, UK on June 22nd - 26th, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance future therapies for HBV, HDV/HBV, HCV, NASH/NAFLD, Gene Editing, Gene Therapy, Drug Metabolism, Pharmacokinetics, and Toxicology.

Topics icon Events

EASL International Liver Congress 2022 in London

American Society of Gene & Therapy (ASGCT) 25th Annual Meeting

PhoenixBio is delighted to be attending ASGCT in person at the Walter E. Washington Convention Center in Washington, DC on May 16 - 19, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.

Topics icon Events

ASGCT2022

Sign-up to our newsletter for the latest news and information straight to your inbox